Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nirmatrelvir/ritonavir and risk of long COVID symptoms: a retrospective cohort study
Seth Congdon, Zev Narrowe, Nang Yone, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17

Showing 17 citing articles:

Association of nirmatrelvir for acute SARS‐CoV‐2 infection with subsequent Long COVID symptoms in an observational cohort study
Matthew S. Durstenfeld, Michael J. Peluso, Feng Lin, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Open Access | Times Cited: 27
Exploring the Complexities of Long COVID
Jackson Donald, Shymaa E. Bilasy, Catherine Yang, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1060-1060
Open Access | Times Cited: 8
Cost-effectiveness of nirmatrelvir/ritonavir for high-risk adult outpatients with COVID-19 in Japan
Takahito Mizuno, Yu Kondo, Mikiyasu Sakai, et al.
Journal of Infection and Chemotherapy (2024) Vol. 30, Iss. 8, pp. 716-724
Closed Access | Times Cited: 5
The efficacy of antivirals, corticosteroids, and monoclonal antibodies as acute COVID-19 treatments in reducing the incidence of long COVID: a systematic review and meta-analysis
Gangqiang Sun, Ke Lin, Jingwen Ai, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 12, pp. 1505-1513
Closed Access | Times Cited: 5
Serum Spike Protein Persistence Post COVID Is Not Associated with ME/CFS
Annick Fehrer, Franziska Sotzny, Laura Kim, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1086-1086
Open Access
Risk of Post-Acute Sequelae of COVID-19 and Oral Antivirals in Adults Aged Over 60 years: A Nationwide Retrospective Cohort Study
Hye Jin Joo, Eunji Kim, Kyungmin Huh, et al.
International Journal of Infectious Diseases (2025), pp. 107850-107850
Open Access
Analysis of risk factors for long COVID after mild COVID-19 during the Omicron wave in Japan
Hotaka Namie, Takahiro Takazono, Rina Kawasaki, et al.
Respiratory Investigation (2025) Vol. 63, Iss. 3, pp. 303-310
Closed Access
Clinical effectiveness of nirmatrelvir plus ritonavir on the short‐ and long‐term outcome in high‐risk children with COVID‐19
Jheng‐Yan Wu, Chia‐Chen Chen, Mei‐Yuan Liu, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 5
Closed Access | Times Cited: 4
Challenges and opportunities in long COVID research
Rebecca E. Hamlin, Catherine A. Blish
Immunity (2024) Vol. 57, Iss. 6, pp. 1195-1214
Closed Access | Times Cited: 3
Nirmatrelvir/ritonavir treatment and risk for postacute sequelae of COVID-19 in older Singaporeans
Liang En Wee, Jue Tao Lim, An Ting Tay, et al.
Clinical Microbiology and Infection (2024) Vol. 31, Iss. 1, pp. 93-100
Closed Access | Times Cited: 3
Effect of Paxlovid Treatment During Acute COVID-19 on Long COVID Onset: An EHR-Based Target Trial Emulation from the N3C and RECOVER Consortia
Alexander Preiss, Abhishek Bhatia, Leyna Aragon, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Persistent Neurological Deficits in Mouse PASC Reveal Antiviral Drug Limitations
Abhishek Kumar Verma, Shea A. Lowery, Li-Chin Lin, et al.
(2024)
Open Access | Times Cited: 1
Developing a clinical-pathological framework of long COVID-related fatigue applied to public safety workers
Adriana Lofrano‐Porto, Susanne D’Isabel, Denise L. Smith
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Long COVID across SARS‐CoV‐2 variants: Clinical features, pathogenesis, and future directions
Laurence S. C. Lok, Shuvam Sarkar, Chi‐Ming Lam, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 4
Closed Access | Times Cited: 1
Nirmatrelvir/ritonavir treatment and the risk of post-COVID condition over 180 days in Malaysia
Ee Vien Low, Mohan Dass Pathmanathan, Y Ten, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Nirmatrelvir plus ritonavir reduces COVID-19 hospitalization and prevents long COVID in adult outpatients
Fatemeh Saheb Sharif‐Askari, Hawra Ali Hussain Alsayed, Narjes Saheb Sharif‐Askari, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Long-term serum spike protein persistence but no correlation with post-COVID syndrome
Annick Fehrer, Franziska Sotzny, Friederike Hoheisel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top